Ketamine & Related Compounds International Journal Club

At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial

Presented on 26 July 2022
Tuesday 26th July 2022 | 12.30pm EST | 5.30pm UK
Thomas D Hull, Matteo Malgaroli, Adam Gazzaley, Teddy J Akiki, Alok Madan, Leonardo Vando, Kristin Arden, Jack Swain, Madeline Klotz, Casey Paleos.
J Affect Disord. 2022 Jul 6;314:59-67. doi: 10.1016/j.jad.2022.07.004. Epub ahead of print. PMID: 35809678
Presenter: T. Derrick Hull, PhD, Institute for Psycholinguistics and Digital Health, United States of America